EnBio Holdings Adjusts Valuation Metrics Amid Mixed Financial Performance Signals

EnBio Holdings, Inc., a microcap company in the miscellaneous industry, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the company's valuation metrics and technical indicators. Notably, the valuation grade has transitioned from fair to attractive, indicating a change in perception regarding its financial standing. The stock's P/E ratio remains unreported due to the company being loss-making, while its price-to-book value stands at 0.67. The enterprise value to EBIT is recorded at 11.15, and the EV to EBITDA ratio is 7.52. Additionally, the enterprise value to capital employed is noted at 0.81, with an EV to sales ratio of 1.08. The return on capital employed (ROCE) is at 7.29%, while the return on equity (ROE) is reported at -2.47%. On the technical side, the trend has shifted from bearish to mildly bearish, with mixed signals across various indicators. Despite a positive financial performance in the quarter ending March 2026, the company has experienced challenges in long-term growth, with net sales increasing at an annual rate of 10.11% over the past five years. For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.